Indications for FIRVANQ:

C. difficile-associated diarrhea. Enterocolitis due to S. aureus.

Limitations of Use:

Oral vancomycin HCl not effective for treatment of other types of infections.

Adult Dosage:

C. difficile-associated diarrhea: 125mg 4 times a day for 10 days. Enterocolitis: 500mg–2g per day in 3–4 divided doses for 7–10 days.

Children Dosage:

40mg/kg per day in 3–4 divided doses for 7–10 days; max 2g/day.

FIRVANQ Warnings/Precautions:

Renal insufficiency and/or colitis. Inflammatory bowel disorders. Underlying hearing loss. Monitor hearing, blood, renal function. Consider monitoring vancomycin serum concentrations. Not for endophthalmitis prophylaxis. Elderly. Pregnancy. Nursing mothers.

FIRVANQ Classification:


FIRVANQ Interactions:

Monitor with aminoglycosides, other neurotoxic, nephrotoxic, or ototoxic drugs.

Adverse Reactions:

Nausea, abdominal pain, hypokalemia; ototoxicity, nephrotoxicity, superinfection.

Generic Drug Availability:


How Supplied:

Kit—1 (w. diluent)

Pricing for FIRVANQ

150ml of 50mg/ml kit (Qty: 1)
Appx. price $147